Nasal Nanoparticle Vaccine Induces a Cross-Strain T-Cell Immunity Against Toxoplasma gondii
Background/Objectives: Toxoplasma gondii is a globally distributed parasite responsible for significant morbidity in both humans and animals. VXN-Toxo, is an intranasal vaccine based on maltodextrin nanoparticles formulated with inactivated T. gondii parasites. A vaccination campaign conducted worldwide in zoological p...